Joseph J. Romano - Concepedia

Concepedia

Author

Joseph J. Romano

United States Military Academy

Also Known As

J. Romano, Joseph J Romano, Joseph J. Romano, Joseph Romano, Joseph J. Romano, Romano, Joseph

39

Publications

1.9K

Citations

17

H-Index

38

Concepts

All Affiliations

United States Military Academy Merck & Co., Inc., Rahway, NJ, USA (United States)GlaxoSmithKline (United States)IRBM Science Park

JJ

About

Joseph J. Romano is an author at United States Military Academy specializing in drug discovery, pharmacology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.5K
2	Natural Sciences	10	10	724
3	Biochemistry	9	9	695
4	Engineering	2	2	124
5	Biomolecular Engineering	2	2	100

Joseph J. Romano

×

19

Publications

1.9K

Citations

16

H-Index

	Year	Citations
Design of amidobenzimidazole STING receptor agonists with systemic activity Joshi M. Ramanjulu, G. Scott Pesiridis, Jingsong Yang, Nature Systemic ActivityMedicineMechanism Of ActionPharmacological AgentPharmacotherapy	2018	803
Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor Steven J. Harper, John A. McCauley, Michael T. Rudd, ACS Medicinal Chemistry Letters ImmunologyMolecular BiologyPharmacotherapyAntiviral DrugMedicinal Chemistry	2012	201
Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor John A. McCauley, Charles McIntyre, Michael T. Rudd, Journal of Medicinal Chemistry ImmunologyAntiviral DrugMedicinal ChemistryViral HepatitisAntiviral Drug Development	2010	176
Molecular Modeling Based Approach to Potent P2−P4 Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease Nigel J. Liverton, M. Katharine Holloway, John A. McCauley, Journal of the American Chemical Society Molecular DockingMedicinal ChemistryInitial CompoundsAntiviral CompoundBiochemistry	2008	134
Novel applications of carbon dioxide/MeOH for the synthesis of hydantoins and cyclic ureas via the Ugi reaction Christopher Hulme, Liang Ma, Joseph J. Romano, Tetrahedron Letters EngineeringBiochemistryNatural SciencesUgi ReactionCarbon Dioxide/meoh	2000	71
Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2-((4-(Benzo[<i>d</i>]thiazol-5-ylamino)-6-(<i>tert</i>-butylsulfonyl)quinazolin-7-yl)oxy)ethyl Dihydrogen Phosphate, for the Treatment of Inflammatory Diseases Pamela A. Haile, Linda Casillas, Bartholomew J. Votta, Journal of Medicinal Chemistry Chronic Inflammatory DiseasesDrug TargetImmunologyCell DeathPathology	2019	65
Novel applications of convertible isonitriles for the synthesis of mono and bicyclic γ-lactams via a UDC strategy Christopher Hulme, Liang Ma, Marie-Pierre Cherrier, Tetrahedron Letters Enantioselective SynthesisConvertible IsonitrilesOrganic ChemistryChemistryPharmacology	2000	60
NR2B-Selective<i>N</i>-Methyl-<scp>d</scp>-aspartate Antagonists: Synthesis and Evaluation of 5-Substituted Benzimidazoles John A. McCauley, Cory R. Theberge, Joseph J. Romano, Journal of Medicinal Chemistry	2004	58
Remarkable three-step-one-pot solution phase preparation of novel imidazolines utilizing a UDC (Ugi/de-Boc/cyclize) strategy Christopher Hulme, Liang Ma, Joseph J. Romano, Tetrahedron Letters Chemical EngineeringEngineeringOrganic ChemistryChemistrySynthesis Method	1999	53
Identification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion Channel Pamela A. Haile, Linda Casillas, Michael J. Bury, ACS Medicinal Chemistry Letters	2018	35

Page 1